Hypoglossal Nerve Stimulation Therapy
The therapy works by delivering gentle, timed electrical stimulation to the nerve that controls tongue movement. This stimulation promotes forward positioning of the tongue during sleep, helping maintain airway patency and reduce breathing disturbances.
The system typically includes an implanted pulse generator placed beneath the skin of the upper chest, a sensing lead that detects respiratory effort, and a stimulation lead that activates the hypoglossal nerve in synchrony with breathing. Following implantation and recovery, device settings are optimized during sleep testing to achieve effective airway stabilization.
Successful outcomes depend on careful patient selection. Candidates usually include adults with documented moderate to severe OSA, appropriate body weight parameters, and a favorable airway collapse pattern confirmed by sleep endoscopy. Clinical studies have shown meaningful reductions in apnea severity, improvements in oxygen saturation, and enhanced daytime functioning in appropriately selected individuals.
As with any surgical therapy, potential risks include discomfort at the implantation site, temporary tongue weakness, or the need for device adjustment. When performed within a structured sleep program, hypoglossal nerve stimulation represents a significant advancement in personalized sleep apnea care, offering improved adherence and quality of life for patients who struggle with traditional therapies.
